APA Alıntı

Kudo, M. (2016). Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma. Liver Cancer.

Chicago Stili Alıntı

Kudo, M. "Regorafenib As Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma." Liver Cancer 2016.

MLA Alıntı

Kudo, M. "Regorafenib As Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma." Liver Cancer 2016.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..